Science Advisory Board
SynCardia’s Science Advisory Board provides valuable scientific support and guidance related to SynCardia technology, manufacturing and clinical use. This includes the development of SynCardia’s future family of pulsatile devices: the 50cc Total Artificial Heart and the 10cc, 30cc and 60cc ventricular assist devices. Each member brings extensive industry experience with biomaterials and implantable medical devices.
Marvin J. Slepian M.D.
Chairman- Director, Tissue Engineering – The University of Arizona
- Professor of Medicine/Cardiology – The University of Arizona
Shmuel Einav Ph.D.
Flow/Hemodynamics- Berman Chair of Vascular Engineering – Tel Aviv University
- Associate Dean of Research – SUNY-Stony Brook
Danny Bluestein Ph.D.
Flow/Hemodynamics- Professor of Bioengineering – SUNY-Stony Brook
- Established Investigator – American Heart Association
- Director, BioFluids Laboratory
Fred J. Schoen M.D., Ph.D.
CV Pathology/Explant Biology- Professor of Pathology and Health Sciences & Technology –
Harvard Medical School
Brigham and Women’s Hospital
Arthur Coury Ph.D.
Biomaterial/Polymer Sciences- Retired Senior Vice President – Biomaterials – Genzyme
- Former President – Society for Biomaterials
Syed F. Hossainy Ph.D.
Biomaterial/Polymer Sciences- Senior Scientist – Abbott Vascular
- Adjunct Assistant Professor, Bioengineering –
Massachusetts Institute of Technology
Paul Nolan PharmD
Coagulation/Anticoagulation- Professor of Pharmacy – The University of Arizona
Frank Tinker Ph.D.
Electro/Mechanical- Da Vinci Research – Tucson, Arizona
NEXT ›› Contact SynCardia
*The SynCardia temporary Total Artificial Heart was formerly known as the
SynCardia temporary CardioWest™ Total Artificial Heart.
SynCardia temporary CardioWest™ Total Artificial Heart.


